Neuropeptides in perspective: The last ten years

Neuron

Volumn 7, Issue 6, 1991, Pages 867-879

  Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ; GALANIN; GLUTAMIC ACID; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTRANSMITTER; SUBSTANCE P;

CENTRAL NERVOUS SYSTEM; GABAERGIC TRANSMISSION; NERVE CELL; NERVE CELL PLASTICITY; NERVE CONDUCTION; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL;

ANIMAL; HUMAN; MODELS, NEUROLOGICAL; NEURONS; NEUROPEPTIDES; NEUROTRANSMITTERS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026323505     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0896-6273(91)90333-U     Document Type: Review

References (172)

1. Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens
2. Peripheral nerve section induces increased levels of calcitonin gene-related peptide (CGRP)-like immunoreactivity in axotomized motoneurons
3. Trophic factors and neuronal survival
4. Comparative observations on the cytologic reactions of central and peripheral nerve cells to axotomy
5. M-15: high-affinity chimeric peptidethat blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord
6. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of medial forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors
7. Galanin and glibenclamide modulate the anoxic release of glutamate in rat CA3 hippocampal neurons
8. Human galanin: primary structure and identification of two molecular forms
9. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260
10. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder
11. Calcitonin gene-related peptide is a potent vasodilator
12. Vasoactive intestinal peptide and electrical activity influence neuronal survival
13. Multiple chemical messengers in hypothalamic magnocellular neurons
14. Retrograde axonal transport of neurotensin in the dopaminergic nigrostriatal pathway in the rat
15. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin-and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus
16. Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist
17. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in demential of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia
18. Amino-acid sequence of substance P
19. Co-localized GABA and somatostatin use different ionic mechanisms to hyperpolarize target neurons in a vertebrate spinal cord
20. Fluorescent antibody methods
21. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study
22. On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepines and beta-carboline derivatives
23. Chemical coding of enteric neurons
24. 2 (FMRFamide) can activate a ligandgated ion channel in Helix neurones
25. The sensory system
26. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord
27. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
28. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings
29. Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats
30. Expression of dopaminergic phenotypes in the mouse olfactory bulb induced by the calcitonin generelated peptide
31. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors
32. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
33. Release, spread and persistence of immunoreactive neurokinin A in the dorsal horn of the cat following noxious cutaneous stimulation. Studies with antibody microprobes
34. Chemical transmission and Dale's principle
35. The importance of the pattern of stimulation in relation to the response of autonomic effectors
36. Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors
37. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin
38. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, auto radiographic, in vivo, and in vitro studies
39. Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve section
40. Design and synthesis of effective antagonists of substance P
41. Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes
42. Calcitonin gene-related peptide and muscle activity regulate acetylcholine receptor alpha-subunit mRNA levels by distinct intracellular pathways
43. Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storagevesicles isolated from ratvas deferens
44. Two principal modes of electrochemical communication in the brain: volume versus wiring transmission
45. Changes from enkephalinlike to gastrinlcholecystokinin-like immunoreactivity in snail neurons
46. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia
47. Pathwayspecific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig
48. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species
49. Exocytosis of secretory granules. A probable mechanism for the release of neuromodulators in invertebrates neuropil
50. Differentiation of delta and mu opiate receptor localizations by light microscopic auto radiography
51. Biochemical and physiological correlates of hypothalamic peptides. The new endocrinology of the neuron
52. Rat facial motoneu ions express increased levels of calcitonin gene-related peptide mRNA in response to axotomy
53. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes
54. The retrograde axonal transport of nerve growth factor
55. Substance P and spinal neurones
56. Molecular characterization of a functional cDNA encoding the rat substance P receptor
57. Effects of sympathectomy and capsaicin treatment on bone remodeling in rats
58. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers
59. Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons
60. Peptidergic neurones
61. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing
62. Coexistence of eptides with classical neurotransmitters
63. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy
64. Identification of two related pentapeptides from the brain with potent opiate agonist activity
65. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity
66. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27
67. 3H-serotonin from tissue slices of rat ventral spinal cord
68. Chick myotubes in culture express high-affinity receptors for calcitonin gene related peptide
69. Substance P: depletion in the dorsal horn of rat spinal cord after section of the peripheral processes of primary sensory neurons
70. mRNA coding for oxytocin is present in axons of the hypothalamin neurohypophysial tract
71. Substance P counteracts neurotoxin damage on norepinephrine neurons in the rat brain during ontogeny
72. Immunohistochemical demonstration of glutaminase in catechoi aminergic and serotonergic neurons of rat brain
73. Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice
74. Direct evidence for concomitant release of noradrenaline, adenosine 5′-triphosphate and neu ropeptide Y from sympathetic nerve supplying the guinea-pig vas cieferens
75. Nerve growth factor stimulates development of substance P in sensory ganglia
76. Regional distribution of neurotensin and somatostatin in rat brain
77. Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys
78. An in vivo model for the neurodegenerative effects of R amyloid and protection by substance P
79. Calcitonin gene-related peptide elevates cyclic AMP levels in chick skeletal muscle: possible neurotrophic role for a coexisting neuronal messenger
80. The action of calcitonin gene-related peptide on astrocyte morphology and cyclic AMP accumulation in astrocyte cultures from neonatal rat brain
81. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation
82. Role of NK, tachykinin receptors in thermonociception: effect of (t )-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice
83. The possible existence of multiple receptors for substance P
84. The nerve growth factor 35 years later
85. The axon reaction: a review of the principal features of perikaryal responses to axon injury
86. Endogenous opioid peptides: multiple agonists and receptors
87. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
88. Coexistence of peptides and classical transmitters
89. Subcellular fractionation of cat submandibular gland: comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP)
90. Costorage of peptides and classical transmitters in neurons
91. VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex
92. Vasoactive intestinal polypeptide induces glycogenolysis in the mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism
93. Calcitonin gene-related peptide staining intensity is reduced in rat lumbar motoneurons after spinal cord transection: a quantitative immunocytochemical study
94. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats
95. cDNA cloning of bovine substance-K receptor through oocyte expression system
96. Differential effect of alpha-latrotoxin on exocytosis from small synaptic vesicles and from large densecore vesicles containing calcitonin gene-related peptide at the frog neuromuscular junction
97. Peptide expression is altered when afferent nerves reinnervate inappropriate tissue
98. Glutamic acid decarboxylase-and gamma-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus
99. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations
100. A galanin-like peptide coexists in putative cholinergic somata of the septum-basal forebrain complex and in acetylcholinesterase-containing fibers and varicosities within the hippocampus in the owl monkey (Aotus trivirgatus)
101. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat
102. Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat: II. Bed nucleus of the stria terminalis and amygdala
103. Iontophoretic application of calciton in gene-related peptide produces a slow and prolonged excitation of neurons in the cat lumbar dorsal horn
104. Cranial motor neurons contain either galanin- or calcitonin gene-related peptide-like immunoreactivity.)
105. Stimulatory effects of substance P on neurite extension and cyclic AMP levels in cultured neuroblastoma cells
106. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis
107. Glutamate-like immunoreactivity in medulla oblongata catecholaminelsubstance P neurons
108. Stimulation of connective tissue cell growth by substance P and substance K
109. Alpha-CGRP and beta-CGRP mRNAs are differentially regulated in the rat spinal cord and dorsal root ganglion
110. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats
111. Calcitonin generelated peptide modulates calcium mobilization in synaptosomes of rat spinal dorsal horn
112. Neurotensin receptors are located on dopamine-containing neurones in rat midbrain
113. Does cholecystokinin colocalize with dopamine in the human substantia nigra?
114. Substance P
115. Calcitonin gene-related peptide (CGRP)-like immunoreactivity and CGRP mRNA in rat spinal cord motoneurons after different types of lesions
116. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts
117. Localization of calcitonin gene-related peptide and its receptors in a striated muscle
118. Substance P modulates glutamate-induced currents in acutely isolated rat spinal dorsal horn neurones
119. Characterization and developmental evolution of a high affinity binding site for calcitonin gene related peptide (CGRP) on chick skeletal muscle membrane
120. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
121. Actions of calcitonin gene-related peptide on rat spinal dorsal horn neurons
122. Polypeptide with broad biological activity: isolation from small intestine
123. Neurotransmitter candidates of somatosensory primary afferent fibres
124. Analysis of expression of cholecystokinin in dopamine cells i n the ventral mesencephalon of several species and in humans with schizophrenia
125. Hypothalamic regulatory hormones
126. Selective excitation of neurons in the mammalian spinal dorsal horn by aspartate and glutamate in vitro: correlation with location and excitatory input
127. Transmitters and peptides in autonomic ganglia
128. Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons
129. Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination
130. Castration reversibly alters levels of cholecystokinin immunoreactivity within cells of three interconnected sexually dimorphic forebrain nuclei in the rat
131. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord
132. Pharmacological evidence that adenosine triphosphate and noradrenaline are cotransmitters in the guinea-pig vas deferens
133. A potent nonpeptide antagonist of the substance P (NK1) receptor
134. Brain peptides as neurotransmitters
135. Dale's hypothesis revisited: different neuropeptides derived from a common prohormone are targeted to different processes
136. Calcitonin gene-related peptide increases in rat facial motoneuronsafter peripheral nerve transection
137. A new natriuretic peptide in porcine brain
138. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze
139. Can specificity ever be proved in immunocytochemical staining
140. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response
141. Identification ofthe motoneuron-depolarizing peptide in bovine dorsal root as hypothalamic substance P
142. Effect of calcitonin gene-related peptide on the cyclic AMP level of isolated mouse diaphragm
143. Structure and functional expression of the cloned rat neurotensin receptor
144. Neuropeptide Y, peptide HI, galanin, cholecystokinin-58, neuropeptide K, and peptide YY
145. The changing scene of neurotrophic factors
146. Exocytosis from neuronal large dense-cored vesicles
147. Calcitonin gene-related peptide prevents disuse-induced sprouting of rat motor nerve terminals
148. Effect of naloxone and d-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain
149. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin
150. Immunoreactive calcitonin gene-related peptide, vasoactive intestinal polypeptide and somatostatin in developing chicken spinal cord motoneurons. Distribution and role in regulation of cAMP in cultured muscle cells
151. Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey
152. Ongoing activity in peripheral nerves: the physiology and pharmacology of impulses originating from a neuroma
153. Muscle but not cutaneous C-afferent input produces prolonged increases i n the excitability of the flexion reflex in the rat
154. Frequency-dependent release of peptide cotransmitters from identified cholinergic motor neurons in Aplysia
155. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
156. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat
157. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes
158. Substance P and NMDA receptors mediatea slow nociceptive ventral root potential in neonatal rat spinal cord
159. Functional role of brain CCK receptors
160. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat
161. Intrathecal galanin antagonizes the facilitatory effect of substance P on the nociceptive flexor reflex in the rat
162. On the role of galanin, substance P and other neuropeptides in primary sensory neurons of rat: studies with spinal reflex excitability and peripheral axotomy
163. PD134308, a selective antagonist of cholecystokinin type-B receptor, prevents morphine tolerance in the rat
164. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
165. Molecular characterization of a functional cDNA for rat substance P receptor
166. A new method for receptor autoradiography: [3H]opioid receptors in rat brain
167. Increased brain size and cellular content in infant rats treated with an opiate antagonist